IMMUNOHEMATOLOGY - ABO - HUMAN ORIGIN - ANVISA Registration 80134860105
Access comprehensive regulatory information for IMMUNOHEMATOLOGY - ABO - HUMAN ORIGIN in Brazil's medical device market through Pure Global AI's free database. This Risk Class IV medical device is registered under ANVISA number 80134860105 and manufactured by manufacturer not specified. The registration is held by GRIFOLS BRASIL LTDA with validity until Apr 23, 2027.
This page provides complete technical specifications for 2 related devices, regulatory compliance details, 5 companies making the same product including DIAGNOSTIC GRIFOLS, S.A., DIAGNOSTIC GRIFOLS, S.A., and 5 recent registrations in the same technical category. Pure Global AI offers free access to over 100,000+ Brazilian medical device registrations, helping global MedTech companies navigate ANVISA regulations, identify competitors, and discover partnership opportunities efficiently.
Related Devices (2)
Registration Details
80134860105
25351330939200641
02513899000171
Company Information
Dates and Status
Apr 23, 2007
23/04/2027
09/18/2025 19:00:01
IMUNOHEMATOLOGIA - ABO - ORIGEM HUMANA
Kit IBMP TR ABO/Rh
INSTITUTO DE BIOLOGIA MOLECULAR DO PARANÁ
80780040019
Sep 25, 2023
IMUNOHEMATOLOGIA - ABO - ORIGEM HUMANA
Família Controle Interno Grupo Sanguíneo e Fator Rh
programa nacional de controle de qualidade ltda
80155020032
Apr 24, 2023
IMUNOHEMATOLOGIA - ABO - ORIGEM HUMANA
Família Reverse-Cyte® 5%
Not specified
80134860273
Dec 28, 2020
IMUNOHEMATOLOGIA - ABO - ORIGEM HUMANA
Família Reverse-Cyte® 5%
MEDION DIAGNOSTICS GRIFOLS AG
80134860273
Dec 28, 2020
IMUNOHEMATOLOGIA - ABO - ORIGEM HUMANA
Reverse-Cyte 0.8%
Not specified
80134860269
Nov 25, 2019

